202 related articles for article (PubMed ID: 31334670)
1. Considerations when restarting anticoagulants in patients with atrial fibrillation after bleeding.
Kozieł M; Ding WY; Kalarus Z; Lip GYH
Expert Rev Hematol; 2019 Oct; 12(10):845-855. PubMed ID: 31334670
[No Abstract] [Full Text] [Related]
2. Restarting of anticoagulation in patients with atrial fibrillation after major bleeding: A meta-analysis.
Zhou Y; Guo Y; Liu D; Feng H; Liu J
J Clin Pharm Ther; 2020 Aug; 45(4):591-601. PubMed ID: 32181518
[TBL] [Abstract][Full Text] [Related]
3. Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy.
Rivera-Caravaca JM; Esteve-Pastor MA; Camelo-Castillo A; Ramírez-Macías I; Lip GYH; Roldán V; Marín F
Expert Opin Pharmacother; 2020 Oct; 21(15):1867-1881. PubMed ID: 32658596
[TBL] [Abstract][Full Text] [Related]
4. Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study.
Forslund T; Wettermark B; Andersen M; Hjemdahl P
Europace; 2018 Mar; 20(3):420-428. PubMed ID: 28177459
[TBL] [Abstract][Full Text] [Related]
5. Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis.
Proietti M; Romiti GF; Romanazzi I; Farcomeni A; Staerk L; Nielsen PB; Lip GYH
Int J Cardiol; 2018 Jun; 261():84-91. PubMed ID: 29572080
[TBL] [Abstract][Full Text] [Related]
6. Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Clin Res Cardiol; 2022 Jan; 111(1):23-33. PubMed ID: 33704551
[TBL] [Abstract][Full Text] [Related]
7. Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.
Kaiser K; Cheng WY; Jensen S; Clayman ML; Thappa A; Schwiep F; Chawla A; Goldberger JJ; Col N; Schein J
Curr Med Res Opin; 2015 Dec; 31(12):2261-72. PubMed ID: 26390360
[TBL] [Abstract][Full Text] [Related]
8. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
[TBL] [Abstract][Full Text] [Related]
9. Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.
Xu WW; Hu SJ; Wu T
J Zhejiang Univ Sci B; 2017 Jul; 18(7):567-576. PubMed ID: 28681581
[TBL] [Abstract][Full Text] [Related]
10. Oral Anticoagulation in Patients With Liver Disease.
Qamar A; Vaduganathan M; Greenberger NJ; Giugliano RP
J Am Coll Cardiol; 2018 May; 71(19):2162-2175. PubMed ID: 29747837
[TBL] [Abstract][Full Text] [Related]
11. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
Potpara TS; Lip GY
Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study.
Balsam P; Ozierański K; Tymińska A; Żukowska K; Zaleska M; Szepietowska K; Maciejewski K; Peller M; Grabowski M; Lodziński P; Praska-Ogińska A; Zaboyska I; Kołtowski Ł; Kowalczuk A; Bednarski J; Filipiak KJ; Opolski G
Kardiol Pol; 2018; 76(5):889-898. PubMed ID: 29350386
[TBL] [Abstract][Full Text] [Related]
13. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
14. Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding.
Little DHW; Sutradhar R; Cerasuolo JO; Perez R; Douketis J; Holbrook A; Paterson JM; Gomes T; Siegal DM
CMAJ; 2021 Mar; 193(9):E304-E309. PubMed ID: 33649169
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries.
Patti G; Pecen L; Lucerna M; Huber K; Rohla M; Renda G; Siller-Matula J; Schnabel RB; Cemin R; Kirchhof P; De Caterina R
Int J Cardiol; 2018 Nov; 270():160-166. PubMed ID: 30220376
[TBL] [Abstract][Full Text] [Related]
16. Decision-making about the use of non-vitamin K oral anticoagulant therapies for patients with atrial fibrillation.
Eckman MH
J Thromb Thrombolysis; 2016 Feb; 41(2):234-40. PubMed ID: 26343041
[TBL] [Abstract][Full Text] [Related]
17. Appropriate doses of non-vitamin K antagonist oral anticoagulants in high-risk subgroups with atrial fibrillation: Systematic review and meta-analysis.
Kim IS; Kim HJ; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
J Cardiol; 2018 Oct; 72(4):284-291. PubMed ID: 29706404
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
[TBL] [Abstract][Full Text] [Related]
19. Role of cardiovascular implantable electronic devices in delivering individualized disease-guided management of patients with non-valvular atrial fibrillation and high bleeding risk.
Mascarenhas DAN; Sharma M; Ziegler PD; Kantharia BK
Acta Cardiol; 2019 Apr; 74(2):131-139. PubMed ID: 29863432
[TBL] [Abstract][Full Text] [Related]
20. Novel oral anticoagulants in cardiovascular disease.
Gallego P; Roldán V; Lip GY
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):34-44. PubMed ID: 24038020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
